Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
jennifer doudna
4
×
life sciences
national blog main
national top stories
san francisco blog main
4
×
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
bristol-myers squibb
celgene
clinical trials
crispr
deals
duchenne muscular dystrophy
eli lilly
fda
feng zhang
gene editing
genentech
glaxosmithkline
What
bio
crispr
roundup
group
adu
alliance
approved
beats
bids
biogen
biopharma
bristol
buy
calls
changing
color
complicated
congress
congressional
create
days
depression
diagnostic
dire
diseases
drug
editing
executives
feud
fix
gene
good
growing
heart
heats
help
high
hours
human
isn’t
Language
unset
Current search:
" jennifer doudna "
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
